Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

M. V. Dieci, A. Frassoldati, D. Generali, G. Bisagni, Federico Piacentini, L. Cavanna, K. Cagossi, F. Puglisi, A. Michelotti, R. Berardi, G. L. Banna, Aicha Goubar, G. Ficarra, G. Griguolo, Pierfranco Conte, V. Guarneri

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1
Number of pages1
JournalBreast Cancer Research and Treatment
DOIs
Publication statusAccepted/In press - Apr 3 2017

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G. L., Goubar, A., Ficarra, G., Griguolo, G., Conte, P., & Guarneri, V. (Accepted/In press). Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials. Breast Cancer Research and Treatment, 1. https://doi.org/10.1007/s10549-017-4219-3